To boost or not to boost : vimarsana.com

To boost or not to boost


This came about following reports that pharmaceutical companies like Pfizer are making plans for such jabs.
Universiti Malaya epidemiologist Prof Datuk Dr Awang Bulgiba Awang Mahmud said local data must be collected to determine how long the Covid-19 vaccines were effective for.
“The rapid evolution of the virus in this pandemic means vaccines need to remain effective against newer variants.
“Booster doses will depend on which vaccines have been administered to vaccine recipients.
“Not all vaccines are equally effective and we need local data for this, ” he said.
Dr Awang Bulgiba, who is the head of the Independent Covid-19 Vaccination Advisory Committee, said it had recommended a voluntary Covid-19 vaccination registry to be set up to compile such data.

Related Keywords

Malaysia , Petaling , Malaysia General , Malaysian , Khairy Jamaluddin , Awang Bulgiba Mahmud , Awang Bulgiba , Baharudin Abdullah , Pfizer , Vaccination Advisory Committee , Astrazeneca , National Immunisation Programme , Us Centers For Disease , Johnson , Malaysian Society Of Allergy , Advisory Committee , Immunisation Programme , Prof Dr Baharudin Abdullah , Disease Control , மலேசியா , இதழ்கள் , மலேசியன் , கைரி ஜமாலுதீன் , ஃபைசர் , தேசிய நோய்த்தடுப்பு ப்ரோக்ராம் , எங்களுக்கு மையங்கள் க்கு நோய் , ஜான்சன் , மலேசியன் சமூகம் ஆஃப் ஒவ்வாமை , நோய்த்தடுப்பு ப்ரோக்ராம் , நோய் கட்டுப்பாடு ,

© 2025 Vimarsana